Dexxa 250 THAIGER PHARMA - 250 mg/ml (10 ml)
Generic name - nandrolone decanoate
Dexxa is an injectable product based on nandrolone decanoate. Nandrolone is commonly used for the treatment of osteoporosis because its positive influence on metabolism of calcium and the increase in the bone mass.
It also has a positive effect on protein metabolism and is used where a protein deficiency needs to be solved - for example after major surgery, severe trauma, or during chronic debilitating diseases.
This product uses enzyme which converts testosterone to the more-potent DHT. Because of that active subsatnce is ending its half-life in the skin, scalp, and prostate. Because of these tissues experience much lower androgen level than the rest of the body. Therefore, for the same amount of activity as another product at the androgen receptors in muscle tissue, Dexxa sustain from activity in the scalp, skin, and prostate.
Thus, it is the best choice for those particularly concerned with common based side effects.
Its effectiveness at the androgen receptor of muscle tissue is superior to that of testosterone.
It also appears less effective or entirely ineffective in activity on nerve cells, certainly on the nerve cells responsible for erectile function. Use of Dexxa as the only product at time often results in erectile dysfunction.
These problems can be solved by combining with a drug that does supply the missing processes - idealy testosterone.
Dexxa moderately effective at doses of 400 mg/week. The long half-life of basis makes it unsuited to short alternating cycles, but suitable for more traditional cycles, with a built-in self-tapering effect in the weeks following the last injection.